A recent study shows that people can be infected with the Ebola virus and not show any symptoms.
Congress passed the 21st Century Cures Act, which reforms the current standards and appropriations for biomedical research and provides five years of funding for the National Institutes of Health and the U.S. Food and Drug Administration.
The U.S. Department of Health and Human Services, along with 15 other agencies, finalized a rule whose provisions safeguard individuals who participate in research, most of which will go into effect in 2018.
Researchers have found that sunlight’s rays speed up helper and killer T cells in the skin.
A new vaccine that blocks the pain-numbing effects of the drugs oxycodone and hydrocodone has shown success in animal models.
Researchers in Melbourne have developed an effective, rapid and economical treatment for Ebola using antibodies from horses.
A new study shows that babies of pregnant women who get the flu or who are vaccinated against the flu do not have an increased risk for Autism Spectrum Disorder.
The American Medical Association and a coalition of 16 other organizations representing physicians, medical groups, hospitals, pharmacists and patients have devised a set of 21 principles to guide reform of utilization management programs.
A Phase I/II study indicates that haplo identical hematopoietic stem cell transplantation (haplo-HSCT), after depletion of α/β T cells and B cells followed by adoptive infusion of donorBPX-501 cells, is an effective alternative for children with primary immunodeficiency disease (PI) in need of an urgent allograft or lacking a suitable human leukocyte antigen (HLA)-matched donor.
Researchers at the Washington University School of Medicine in St. Louis have discovered the reason the BCG vaccine and investigational vaccine candidates are not more effective.
Because many of the current treatments for autoimmune diseases leave patients at greater risk of developing other opportunistic illnesses, a research team at the University of Oxford in England has been using genetics to possibly minimize the side effects of treatment.
The U.S. Department of Health andHuman Services has selected nearly 200 physician group practices and 17health insurance companies to participate in a care delivery model that supports and encourages higher quality and more coordinated cancer care.
